Enovis (ENOV) Current Deferred Revenue (2010 - 2011)
Enovis (ENOV) posted quarterly Current Deferred Revenue of $14.7 million for Q4 2011, down 14.76% year-over-year from $17.2 million in Q4 2010, and up 8.25% quarter-over-quarter from $13.6 million in Q3 2011.
Enovis (ENOV) Current Deferred Revenue (2010 - 2011) Analysis & Trends
Enovis (ENOV) has reported Current Deferred Revenue for 2 consecutive years, with $14.7 million the latest figure, recorded in Q4 2011.
- In Q4 2011, Current Deferred Revenue fell 14.76% year-over-year to $14.7 million; the TTM figure through Dec 2011 stood at $14.7 million (down 14.76% YoY), while the FY2011 annual figure was $14.7 million, down 14.76% from the prior year.
- Current Deferred Revenue grew to $14.7 million in Q4 2011 per ENOV's latest filing, from $13.6 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $22.2 million in Q3 2011 and bottomed at $13.6 million in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Enovis | 1.52 Bn | 1.51 Bn | 359.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 14.70 Mn |
| Sep 30, 2011 | 13.58 Mn |
| Jul 1, 2011 | 22.19 Mn |
| Dec 31, 2010 | 17.25 Mn |